Early-Stop study tests smoking help for schizophrenia patients
NCT ID NCT06374290
Summary
This small pilot study tested whether two medications (injectable naltrexone and oral bupropion) could help people with schizophrenia quit smoking. The study aimed to check if this approach was safe and practical for this population. Only 2 people participated before the study was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas health Science Center at Houston
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.